We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.48B
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.65% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Industrials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Intellia Therapeutics
NTLA
$1.6B
| $45M | 0.1% |
619,600
+69,210
| +13% | +$5.86M |
|
252
Trip.com Group
TCOM
$24.8B
| $44.9M | 0.1% |
1,941,642
+813,874
| +72% | +$20.5M |
|
253
Apollo Global Management
APO
$75.2B
| $44.5M | 0.1% |
+718,400
| New | +$47.2M |
|
254
AstraZeneca
AZN
$253B
| $44.3M | 0.1% |
333,982
-253,986
| -43% | -$30.5M |
|
255
Dutch Bros
BROS
$5.83B
| $44.2M | 0.1% |
800,000
+200,000
| +33% | +$10.2M |
|
|
BERY
256
DELISTED
Berry Global Group, Inc.
BERY
| $44.1M | 0.1% |
828,360
-11,466
| -1% | -$671K |
|
257
Zentalis Pharmaceuticals
ZNTL
$299M
| $43.9M | 0.1% |
950,933
-23,727
| -2% | -$1.28M |
|
258
Custom Truck One Source
CTOS
$2.03B
| $43.6M | 0.1% |
5,197,435
-160,000
| -3% | -$1.29M |
|
|
NATI
259
DELISTED
National Instruments Corp
NATI
| $43.2M | 0.1% |
1,065,192
-138,489
| -12% | -$5.59M |
|
260
Occidental Petroleum
OXY
$63.6B
| $43.2M | 0.1% |
760,896
+300,434
| +65% | +$13.3M |
|
|
AYX
261
DELISTED
Alteryx Inc
AYX
| $42.9M | 0.1% |
600,000
+200,000
| +50% | +$11.8M |
|
|
SBNY
262
DELISTED
Signature Bank
SBNY
| $42.7M | 0.1% |
145,571
-25,920
| -15% | -$8.42M |
|
263
Dow Inc
DOW
$21.5B
| $42.7M | 0.1% |
670,029
-24,607
| -4% | -$1.48M |
|
|
COUP
264
DELISTED
Coupa Software Incorporated
COUP
| $42.4M | 0.1% |
416,824
+6,613
| +2% | +$800K |
|
265
Northern Trust
NTRS
$32.6B
| $42.3M | 0.1% |
362,858
-2,411
| -0.7% | -$286K |
|
266
Allegro MicroSystems
ALGM
$6.21B
| $42.2M | 0.1% |
1,485,592
+77
| +0% | +$2.2K |
|
267
Exelon
EXC
$43.7B
| $41.8M | 0.09% |
877,044
-58,809
| -6% | -$2.49M |
|
|
NAPA
268
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $41.5M | 0.09% |
2,279,202
+159,389
| +8% | +$3.11M |
|
269
Analog Devices
ADI
$175B
| $41.2M | 0.09% |
249,633
-1,655
| -0.7% | -$268K |
|
270
Honeywell
HON
$63.6B
| $41M | 0.09% |
223,370
-13,297
| -6% | -$2.46M |
|
|
BNY
271
Bank of New York Mellon
BNY
$105B
| $40.7M | 0.09% |
819,070
+273,206
| +50% | +$15.5M |
|
|
DEA
272
Easterly Government Properties
DEA
$1.12B
| $40.4M | 0.09% |
764,372
+32,372
| +4% | +$1.72M |
|
273
Gartner
IT
$12.7B
| $40.3M | 0.09% |
135,590
-67,686
| -33% | -$19.6M |
|
274
Intuitive Surgical
ISRG
$133B
| $40.2M | 0.09% |
133,115
-4,892
| -4% | -$1.43M |
|
275
Natera
NTRA
$50.2B
| $40.1M | 0.09% |
985,434
-968,387
| -50% | -$58.2M |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.